← Back to Search

ClariVein RES 1% Injection for Venous Insufficiency (VICARES Trial)

Phase 2
Waitlist Available
Research Sponsored by Vascular Insights, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Summary

This trial is testing two different strengths of a solution to treat venous insufficiency, a condition where the veins are not able to properly send blood back to the heart. The trial will compare how well the two solutions work, and ClariVein is a system that will be used to deliver the solution.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Pruritus
Secondary study objectives
Elimination of Saphenous Vein Reflux

Trial Design

2Treatment groups
Active Control
Group I: ClariVein RES 1% InjectionActive Control2 Interventions
Sodium Tetradecyl Sulfate 1% Injection single administration
Group II: ClariVein RES 3% InjectionActive Control2 Interventions
Sodium Tetradecyl Sulfate 3% Injection single administration

Find a Location

Who is running the clinical trial?

Vascular Insights, LLCLead Sponsor
Mark H Meissner, MDStudy ChairVascular and Endovascular Surgery Clinic at UWMC
~2 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top